BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fralick M, Kesselheim AS, Avorn J, Schneeweiss S. Use of Health Care Databases to Support Supplemental Indications of Approved Medications. JAMA Intern Med. 2018;178:55-63. [PMID: 29159410 DOI: 10.1001/jamainternmed.2017.3919] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Varma VR, Desai RJ, Navakkode S, Wong LW, Anerillas C, Loeffler T, Schilcher I, Mahesri M, Chin K, Horton DB, Kim SC, Gerhard T, Segal JB, Schneeweiss S, Gorospe M, Sajikumar S, Thambisetty M. Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease. Mol Psychiatry 2022. [PMID: 36577843 DOI: 10.1038/s41380-022-01912-0] [Reference Citation Analysis]
2 Baptiste PJ, Wong AY, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, Mann JF, Cunnington M, Teo K, Bangdiwala SI, Gao P, Tomlinson L, Wing K. Cardiorenal Effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with validation against a target trial.. [DOI: 10.1101/2022.12.02.22282220] [Reference Citation Analysis]
3 Desai RJ, Glynn RJ, Everett BM, Schneeweiss S, Wexler DJ, Bessette LG, Déruaz-Luyet A, Vedin O, Brodovicz K, Patorno E. Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care. Am Heart J 2022;254:203-15. [PMID: 36150454 DOI: 10.1016/j.ahj.2022.09.008] [Reference Citation Analysis]
4 Tan WK, Segal BD, Curtis MD, Baxi SS, Capra WB, Garrett-Mayer E, Hobbs BP, Hong DS, Hubbard RA, Zhu J, Sarkar S, Samant M. Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations. Contemp Clin Trials Commun 2022;30:101000. [PMID: 36186544 DOI: 10.1016/j.conctc.2022.101000] [Reference Citation Analysis]
5 Roh M, Tesfaye H, Kim SC, Zabotka LE, Patorno E. Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic Retinopathy. Ophthalmol Retina 2022;6:1145-53. [PMID: 35777664 DOI: 10.1016/j.oret.2022.06.010] [Reference Citation Analysis]
6 Salinas CA, Louder A, Polinski J, Zhang TC, Bower H, Phillips S, Song Y, Rashidi E, Bosan R, Chang H, Foster N, Gershenson B, Yamanaka H, Kishimoto M, Tanaka Y, Fischer P, Zhu B, Faries D, Mai X, Doherty BT, Grelaud A, Thurin NH, Askling J, Deberdt W, the B023 Study Consortium. Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases. Rheumatol Ther 2022. [DOI: 10.1007/s40744-022-00505-1] [Reference Citation Analysis]
7 Hamelin B, Rowe P, Molony C, Kruger M, Locasale R, Khan AH, Jacob-nara J, Jacob D. Immunolab: Combining targeted real-world data with advanced analytics to generate evidence at scale in immunology. Front Allergy 2022;3. [DOI: 10.3389/falgy.2022.951795] [Reference Citation Analysis]
8 Desai RJ, Mahesri M, Lee SB, Varma VR, Loeffler T, Schilcher I, Gerhard T, Segal JB, Ritchey ME, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study. Brain Commun 2022;4:fcac247. [PMID: 36330433 DOI: 10.1093/braincomms/fcac247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhuo M, D'Andrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Patorno E. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes. JAMA Netw Open 2022;5:e2235995. [PMID: 36219443 DOI: 10.1001/jamanetworkopen.2022.35995] [Reference Citation Analysis]
10 Hou J, Zhao R, Cai T, Beaulieu-Jones B, Seyok T, Dahal K, Yuan Q, Xiong X, Bonzel CL, Fox C, Christiani DC, Jemielita T, Liao KP, Liaw KL, Cai T. Temporal Trends in Clinical Evidence of 5-Year Survival Within Electronic Health Records Among Patients With Early-Stage Colon Cancer Managed With Laparoscopy-Assisted Colectomy vs Open Colectomy. JAMA Netw Open 2022;5:e2218371. [PMID: 35737384 DOI: 10.1001/jamanetworkopen.2022.18371] [Reference Citation Analysis]
11 Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents. JAMA Netw Open 2022;5:e226567. [PMID: 35394510 DOI: 10.1001/jamanetworkopen.2022.6567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hek K, Rolfes L, van Puijenbroek EP, Flinterman LE, Vorstenbosch S, van Dijk L, Verheij RA. Electronic Health Record-Triggered Research Infrastructure Combining Real-world Electronic Health Record Data and Patient-Reported Outcomes to Detect Benefits, Risks, and Impact of Medication: Development Study. JMIR Med Inform 2022;10:e33250. [PMID: 35293877 DOI: 10.2196/33250] [Reference Citation Analysis]
13 Lin LA, Zhang Y, Straus W, Wang W. Integrative Analysis of Randomized Clinical Trial and Observational Study Data to Inform Post-marketing Safety Decision-Making. Ther Innov Regul Sci 2022. [PMID: 35138577 DOI: 10.1007/s43441-021-00349-x] [Reference Citation Analysis]
14 Shao SC, Su YC, Lai EC, Chang KC, Lee CN, Hung MJ, Lai CC, Huang FC, Hung JH. Association between Sodium Glucose Co-transporter 2 Inhibitors and Incident Glaucoma in Patients with Type 2 Diabetes: A Multi-institutional Cohort Study in Taiwan. Diabetes Metab 2022;:101318. [PMID: 35017100 DOI: 10.1016/j.diabet.2022.101318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Young JC, Dasgupta N, Chidgey BA, Stürmer T, Pate V, Hudgens M, Jonsson Funk M. Impacts of Initial Prescription Length and Prescribing Limits on Risk of Prolonged Postsurgical Opioid Use. Med Care 2022;60:75-82. [PMID: 34812786 DOI: 10.1097/MLR.0000000000001663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Anwendung evidenzbasierter Medizin. Public Health 2022. [DOI: 10.1016/b978-3-437-22262-7.00052-1] [Reference Citation Analysis]
17 Zhuo M, Paik JM, Wexler DJ, Bonventre JV, Kim SC, Patorno E. SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes. Am J Kidney Dis 2021:S0272-6386(21)00953-7. [PMID: 34762974 DOI: 10.1053/j.ajkd.2021.09.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Reynor A, McArdle N, Shenoy B, Dhaliwal SS, Rea SC, Walsh J, Eastwood PR, Maddison K, Hillman DR, Ling I, Keenan BT, Maislin G, Magalang U, Pack AI, Mazzotti DR, Lee CH, Singh B. Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: Are participants of randomized trials representative of sleep clinic patients? Sleep 2021:zsab264. [PMID: 34739082 DOI: 10.1093/sleep/zsab264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Masarwa R, Lefebvre C, Platt RW, Filion KB. General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998-2018. Pharmacoepidemiol Drug Saf 2021. [PMID: 34708900 DOI: 10.1002/pds.5377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Franchetti Y. Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical Equations. J Clin Pharmacol 2021. [PMID: 34671990 DOI: 10.1002/jcph.1989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wallach JD, Deng Y, McCoy RG, Dhruva SS, Herrin J, Berkowitz A, Polley EC, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Shah ND, Ross JS, Lyon TD. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment. JAMA Netw Open 2021;4:e2130587. [PMID: 34677594 DOI: 10.1001/jamanetworkopen.2021.30587] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
22 Hassan TA, Sáenz JE, Ducinskiene D, Cook JP, Imperato JS, Zou KH. New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review. J Multidiscip Healthc 2021;14:2453-65. [PMID: 34522102 DOI: 10.2147/JMDH.S313626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
23 Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health Technol Assess 2021;25:1-70. [PMID: 34463610 DOI: 10.3310/hta25510] [Reference Citation Analysis]
24 Brown JP, Douglas IJ, Hanif S, Thwaites RMA, Bate A. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact. Value Health 2021;24:1241-4. [PMID: 34452702 DOI: 10.1016/j.jval.2021.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Tadrous M, Ahuja T, Ghosh B, Kropp R. Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle. Healthc Policy 2020;15:41-7. [PMID: 32538348 DOI: 10.12927/hcpol.2020.26225] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Fralick M, Schneeweiss S, Redelmeier DA, Razak F, Gomes T, Patorno E. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care. Diabetes Obes Metab 2021;23:2320-8. [PMID: 34169619 DOI: 10.1111/dom.14474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Rogers JR, Lee J, Zhou Z, Cheung YK, Hripcsak G, Weng C. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review. J Am Med Inform Assoc 2021;28:144-54. [PMID: 33164065 DOI: 10.1093/jamia/ocaa224] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
28 Shepshelovich D, Yahav D, Ben Ami R, Goldvaser H, Tau N. Concordance between the results of randomized and non-randomized interventional clinical trials assessing the efficacy of drugs for COVID-19: a cross-sectional study. J Antimicrob Chemother 2021:dkab163. [PMID: 34075419 DOI: 10.1093/jac/dkab163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Simon GE, Platt R, Watanabe JH, Bindman AB, John London A, Horberg M, Hernandez A, Califf RM. When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments? Clin Pharmacol Ther 2021. [PMID: 33895994 DOI: 10.1002/cpt.2253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Fralick M, Kulldorff M, Redelmeier D, Wang SV, Vine S, Schneeweiss S, Patorno E. A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes. Endocrinol Diabetes Metab 2021;4:e00237. [PMID: 34277962 DOI: 10.1002/edm2.237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I. Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials. Eur Respir J 2021;57:2001586. [PMID: 33093119 DOI: 10.1183/13993003.01586-2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
32 Suissa K, Schneeweiss S, Kim DW, Patorno E. Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States. Diabetes Obes Metab 2021;23:1542-51. [PMID: 33651454 DOI: 10.1111/dom.14367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
33 Baptiste P, Wong AY, Schultze A, Cunnington M, Mann JF, Clase C, Leyrat C, Tomlinson L, Wing K. Real-world effects of ACE inhibitors and Angiotensin Receptor Blockers: protocol for an emulation study of the ONTARGET trial using electronic health records.. [DOI: 10.1101/2021.03.15.21251990] [Reference Citation Analysis]
34 Chen J, Ho M, Lee K, Song Y, Fang Y, Goldstein BA, He W, Irony T, Jiang Q, van der Laan M, Lee H, Lin X, Meng Z, Mishra-kalyani P, Rockhold F, Wang H, White R. The Current Landscape in Biostatistics of Real-World Data and Evidence: Clinical Study Design and Analysis. Statistics in Biopharmaceutical Research. [DOI: 10.1080/19466315.2021.1883474] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
35 Schneeweiss S, Patorno E. Conducting real-world evidence studies on the clinical outcomes of diabetes treatments. Endocr Rev 2021:bnab007. [PMID: 33710268 DOI: 10.1210/endrev/bnab007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
36 Vanner EA, Sun CQ, McSoley MJ, Persad PJ, Feuer WJ, Lum F, Kelly S, Parrish RK, Chang TC, Gedde SJ. Reply to Comment on: The Tube Versus Trabeculectomy IRIS Registry Study: Cohort Selection and Follow-up and Comparisons to the Randomized Controlled Trial. Am J Ophthalmol 2021:S0002-9394(21)00094-5. [PMID: 33676946 DOI: 10.1016/j.ajo.2021.02.029] [Reference Citation Analysis]
37 Rabiolo A, McNaught AI, Caprioli J. Comment on: The Tube Versus Trabeculectomy IRIS® Registry Study: Cohort Selection and Follow-up and Comparisons to the Randomized Controlled Trial. Am J Ophthalmol 2021:S0002-9394(21)00093-3. [PMID: 33675754 DOI: 10.1016/j.ajo.2021.02.028] [Reference Citation Analysis]
38 Rassen JA, Murk W, Schneeweiss S. Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in bias. Diabetes Obes Metab 2021;23:1453-62. [PMID: 33566434 DOI: 10.1111/dom.14338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Harvey PR, Trudgill NJ. The association between physician staff numbers and mortality in English hospitals. EClinicalMedicine 2021;32:100709. [PMID: 33681734 DOI: 10.1016/j.eclinm.2020.100709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
40 Yarnell CJ, Thiruchelvam D, Redelmeier DA. Risks of Serious Injury with Testosterone Treatment. Am J Med 2021;134:84-94.e6. [PMID: 32926849 DOI: 10.1016/j.amjmed.2020.07.037] [Reference Citation Analysis]
41 Colombo F, Oderkirk J, Slawomirski L. Health Information Systems, Electronic Medical Records, and Big Data in Global Healthcare. Handbook of Global Health 2021. [DOI: 10.1007/978-3-030-45009-0_71] [Reference Citation Analysis]
42 Seesaghur A, Petruski-Ivleva N, Banks V, Wang JR, Mattox P, Hoeben E, Maskell J, Neasham D, Reynolds SL, Kafatos G. Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database. Pharmacoepidemiol Drug Saf 2021;30:248-56. [PMID: 33174338 DOI: 10.1002/pds.5171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Fralick M, Bartsch E, Darrow JJ, Kesselheim AS. Understanding when real world data can be used to replicate a clinical trial: A cross-sectional study of medications approved in 2011. Pharmacoepidemiol Drug Saf 2020;29:1273-8. [PMID: 32798299 DOI: 10.1002/pds.5086] [Reference Citation Analysis]
44 Kim DH, Lee JE, Kim YG, Lee Y, Seo DW, Lee KH, Lee JH, Kim WS, Kim YH, Oh JS. High-Throughput Algorithm for Discovering New Drug Indications by Utilizing Large-Scale Electronic Medical Record Data. Clin Pharmacol Ther 2020;108:1299-307. [PMID: 32621536 DOI: 10.1002/cpt.1980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
45 Esserman D, Goldstein BA, Levenson M, Platt R, Roe MT, Zeliadt S. University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records in randomized clinical trials-challenges and opportunities (morning panel session). Clin Trials 2020;17:405-13. [PMID: 32615793 DOI: 10.1177/1740774520928607] [Reference Citation Analysis]
46 Coleman CI, Dobesh PP, Danese S, Ulloa J, Lovelace B. Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study. Future Cardiol 2021;17:127-35. [PMID: 32618210 DOI: 10.2217/fca-2020-0073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
47 Althunian TA, de Boer A, Groenwold RHH, Rengerink KO, Souverein PC, Klungel OH. Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf 2020;29:1263-72. [PMID: 32537897 DOI: 10.1002/pds.5065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Schneeweiss MC, Merola JF, Schneeweiss S, Wyss R, Rosmarin D. Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2021;35:195-202. [PMID: 32531094 DOI: 10.1111/jdv.16728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 Schneeweiss MC, Huang JT, Wyss R, Schneeweiss S, Merola JF. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study. Journal of the American Academy of Dermatology 2020;82:1337-45. [DOI: 10.1016/j.jaad.2020.02.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
50 Spoendlin J, Desai RJ, Franklin JM, Glynn RJ, Payne E, Schneeweiss S. Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis. Clin Pharmacol Ther 2020;108:874-84. [PMID: 32320482 DOI: 10.1002/cpt.1861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Huang Bartlett C, Mardekian J, Cotter MJ, Huang X, Zhang Z, Parrinello CM, Bourla AB. Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer. PLoS One 2020;15:e0227256. [PMID: 32315295 DOI: 10.1371/journal.pone.0227256] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
52 Fralick M, Kesselheim AS. Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis. Pharmacoepidemiol Drug Saf 2020;29:1322-4. [PMID: 32189390 DOI: 10.1002/pds.4994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Lasky T, Carleton B, Horton DB, Kelly LE, Bennett D, Czaja AS, Gifkins D, Osokogu OU, McMahon AW. Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review. Drugs Real World Outcomes 2020;7:97-107. [PMID: 32112359 DOI: 10.1007/s40801-020-00182-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
54 Fralick M, Sacks CA, Kesselheim AS. Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect. JAMA Intern Med 2019;179:224-30. [PMID: 30615021 DOI: 10.1001/jamainternmed.2018.6112] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
55 Fralick M, Chen SK, Patorno E, Kim SC. Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study. Ann Intern Med 2020;172:186-94. [PMID: 31931526 DOI: 10.7326/M19-2610] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
56 Kim SC, Schneeweiss S. When Randomized Clinical Trials and Real‐World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety. Arthritis Rheumatol 2019;72:4-6. [DOI: 10.1002/art.41092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Gagne JJ, Avorn J. The Role of Pharmacoepidemiology in the Healthcare System and Academia. Pharmacoepidemiology 2019. [DOI: 10.1002/9781119413431.ch6] [Reference Citation Analysis]
58 Fralick M, Schneeweiss S, Wallis CJD, Jung EH, Kesselheim AS. Desmopressin and the risk of hyponatremia: A population-based cohort study. PLoS Med 2019;16:e1002930. [PMID: 31634354 DOI: 10.1371/journal.pmed.1002930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
59 Chau I, Le DT, Ott PA, Korytowsky B, Le H, Le TK, Zhang Y, Sanchez T, Maglinte GA, Laurie M, Abraham P, Patel D, Shangguan T. Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer. Gastric Cancer 2020;23:133-41. [PMID: 31549264 DOI: 10.1007/s10120-019-01008-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
60 Schneeweiss S, Glynn RJ. Real-World Data Analytics Fit for Regulatory Decision-Making. Am J Law Med 2018;44:197-217. [PMID: 30106649 DOI: 10.1177/0098858818789429] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
61 Hall-Lipsy E, Barraza L, Robertson C. Practice-Based Research Networks and the Mandate for Real-World Evidence. Am J Law Med 2018;44:219-36. [PMID: 30106651 DOI: 10.1177/0098858818789428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
62 Schneeweiss S, Brown JS, Bate A, Trifirò G, Bartels DB. Choosing Among Common Data Models for Real-World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products. Clin Pharmacol Ther 2020;107:827-33. [PMID: 31330042 DOI: 10.1002/cpt.1577] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
63 Crown WH. Real-World Evidence, Causal Inference, and Machine Learning. Value Health 2019;22:587-92. [PMID: 31104739 DOI: 10.1016/j.jval.2019.03.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
64 Rejon-Parrilla JC, Jonsson P, Bouvy JC. Key enablers and barriers to implementing adaptive pathways in the European setting. Br J Clin Pharmacol 2019;85:1427-33. [PMID: 30849187 DOI: 10.1111/bcp.13916] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Patorno E, Pawar A, Franklin JM, Najafzadeh M, Déruaz-Luyet A, Brodovicz KG, Sambevski S, Bessette LG, Santiago Ortiz AJ, Kulldorff M, Schneeweiss S. Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care. Circulation 2019;139:2822-30. [PMID: 30955357 DOI: 10.1161/CIRCULATIONAHA.118.039177] [Cited by in Crossref: 129] [Cited by in F6Publishing: 136] [Article Influence: 32.3] [Reference Citation Analysis]
66 Franklin JM, Glynn RJ, Martin D, Schneeweiss S. Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making. Clin Pharmacol Ther 2019;105:867-77. [PMID: 30636285 DOI: 10.1002/cpt.1351] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 20.5] [Reference Citation Analysis]
67 Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. Fracture Risk After Initiation of Use of Canagliflozin: A Cohort Study. Ann Intern Med. 2019;. [PMID: 30597484 DOI: 10.7326/m18-0567] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 15.8] [Reference Citation Analysis]
68 Chen VC, Chan H, Hsu T, Lu M, Lee Y, Lee Y, Siow JY, Mcintyre RS, Zhou AJ, Tzang B, Lee CT. New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinoma. Int J Cancer 2019;144:2428-39. [DOI: 10.1002/ijc.31980] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
69 Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257 [PMID: 30588287 DOI: 10.4239/wjd.v9.i12.252] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
70 Eichler HG, Bloechl-Daum B, Broich K, Kyrle PA, Oderkirk J, Rasi G, Santos Ivo R, Schuurman A, Senderovitz T, Slawomirski L, Wenzl M, Paris V. Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals? Clin Pharmacol Ther 2019;105:912-22. [PMID: 30178490 DOI: 10.1002/cpt.1226] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 11.8] [Reference Citation Analysis]
71 Michael Fralick, Chana A. Sacks, Aaron S. Kesselheim. Assessment of Off-label Prescribing Compared With FDA-Approved Treatment With Combined Dextromethorphan and Quinidine in 2 Commercial Insurance Databases. JAMA Intern Med 2018;178. [PMID: 30039158 DOI: 10.1001/jamainternmed.2018.3016] [Reference Citation Analysis]
72 Weng X. Real-world evidence approach to traditional herbal medicinal products. Drug Discovery Today 2018;23:1321-1323. [DOI: 10.1016/j.drudis.2018.05.008] [Reference Citation Analysis]
73 Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study. PLoS Med 2018;15:e1002584. [PMID: 29889841 DOI: 10.1371/journal.pmed.1002584] [Cited by in Crossref: 57] [Cited by in F6Publishing: 63] [Article Influence: 11.4] [Reference Citation Analysis]
74 Cai C, Fang J, Guo P, Wang Q, Hong H, Moslehi J, Cheng F. In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers. J Chem Inf Model 2018;58:943-56. [PMID: 29712429 DOI: 10.1021/acs.jcim.7b00641] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
75 Agarwala V, Khozin S, Singal G, O’connell C, Kuk D, Li G, Gossai A, Miller V, Abernethy AP. Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study. Health Affairs 2018;37:765-72. [DOI: 10.1377/hlthaff.2017.1579] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
76 Wang CC, Wu CK, Tsai ML, Lee CM, Huang WC, Chou HH, Huang JL, Chi NH, Yen HW, Tzeng BH, Chang WT, Chang HY, Wang CH, Lu YY, Tsai JP, Su CH, Cherng WJ, Yin WH, Tsai CT, Wu YW, Lin JL, Hwang JJ. 2019 Focused Update of the Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure. Acta Cardiol Sin 2019;35:244-83. [PMID: 31249457 DOI: 10.6515/ACS.201905_35(3).20190422A] [Cited by in F6Publishing: 15] [Reference Citation Analysis]